Oncology

People with pale skin, freckles, and red hair carry mutations comparable to an extra 21 years of sun exposure.

Approximately 7000 studies involved contaminated HEp-2 and INT 407 cell lines.

Overexpression of Aurora Kinase could potentially inhibit a tumor suppressing gene.

Fluorescence lifetime imaging identifies which breast cancer patients will benefit from specific treatments.

Neratinib and the combination of veliparib plus carboplatin improves breast cancer outcomes.

Anti-PD-L1 immunotherapy with an MEK inhibitor may improve treatment of microsatellite-stable metastatic colorectal cancer.

Researchers created an algorithm that can discover how the immune system responds to cancer.

Microscopic silk swimming device may improve treatment for variety of diseases.

In-depth examination of the mechanisms of a tumor protein could lead to new treatments.

Stage 2 colon cancer patients administered adjuvant chemotherapy survived significantly longer than patients who did not.

Support groups and social networking help breast cancer patients manage emotions and stress.

New models can improve accuracy of cancer research.

Approximately 1 in 100 patients with MGUS develop myeloma.

Burdock root, or gobo, associated with lower rates of colon cancer and colitis.

Chemotherapy drug may cause the loss of hearing during the treatment of testicular cancer.

Overexpression of Aurora Kinase could potentially inhibit a tumor suppressing gene.

Approximately 12.3% of patients diagnosed with heart failure were diagnosed with cancer.

Top news of the week from across the health care landscape.

Research could lead to improved personalized therapies for acute myeloid leukemia.

Selenocompounds were able to kill up to 80% of cancer cells in mice.

Patients treated for high cholesterol showed improved survival in bowel, breast, lung, and prostate cancers.

Analysis of HOX gene able to predict survival in ovarian cancer.

Altered TRPV6 expression is linked to cancer and other diseases.

Participants who lost weight showed decreased expression of proteins that promote tumor-related angiogenesis.

Vemurafenib is a multi-targeted kinase inhibitor originally approved to treat melanoma patients with a BRAF mutation.

Top news of the day from across the health care landscape.

Compounds found in turmeric and milk thistle inhibit the spread of cancer cells.

A novel technique could resolve current problems with photo-thermal therapy for cancer treatment.